Mytheos Holt

Mytheos Holt is Senior Fellow in the Freedom to Innovate at the Institute for Liberty. He has held positions at the R Street Institute, Mair Strategies, TheBlaze, and National Review. He also worked as a speechwriter for U.S. Sen. John Barrasso  His writing on video games has been featured at TheBlaze, Gamesided, the Escapist, and the Federalist. He hails originally from Big Sur, California, but currently lives in Arlington, Virginia. Yes, Mytheos is his real name.

President Trump’s Jangling Keys Approach Is Working

 

It is a point of cliché that one of the most effective ways to distract a toddler is to shake keys in front of their faces. What has become obvious over the past two weeks is that the same approach works to distract the mental toddlers of the mainstream media. It is scarcely necessary to […]

Continue Reading

Don’t Let Big Pharma Imitate Obamacare

 

“Repeal and replace” as a concept was always elegant, particularly as a campaign slogan. In practice, it is consistently proving itself to be harder than its proponents imagined. As with the AHCA before it, it appears that the Senate bill designed to repeal Obamacare is running smack into a moat of disparate GOP visions for […]

Continue Reading

The Star Wars Era Is Back and Not Just in the Movies

 

As any American of any postliterate age can tell you, the “Star Wars” saga has come back in a big way over the past few years in cinema. Furthermore, the Trump administration seems intent on reproducing the symbolism and political norms of the era when Star Wars most dominated the American conversation – namely, the […]

Continue Reading

Mr. President, Don’t Suck Up to Industries That Hate You

 

In the past week, two news items came out of the Trump White House that should trouble supporters of the President’s populist agenda, and should send warning bells about the advice that President Trump may be receiving from his inner circle. The first was the bewildering lovefest between Trump and tech titans such as Jeff […]

Continue Reading

Don’t Let the Door Hit You, Elon

 

Last week, after President Trump’s historic decision to back out of the Paris Climate Accords, effectively keeping his promise to put America First, dissent flew from the usual corners with nauseating frequency. However, one critic might have surprised a few observers, given his previous dogged insistence on being close to President Trump. That person was […]

Continue Reading

The Trump Family Should Be the Gold Standard for Invention

 

When it comes to the area of patent law, the Trump touch is desperately needed. No living politician has shown a better capacity to cut through the rationalizations of Leftists, legalistic regulators, and special interests to find a solution that will make America great again, and make no mistake, all three groups are opposed to […]

Continue Reading

TC Heartland Is Not a Magic Bullet

 

Early this week, the Supreme Court dropped yet another historic ruling on the subject of patent law. In fact, not only was the decision historic, but it was historically correct. That case, TC Heartland v. Kraft, a seemingly innocuous dispute over flavored drink mixes, amounts to a sweeping rejection of the legal strategy employed by […]

Continue Reading

Blue Cross Blows Big Pharma’s Cover

 

With healthcare reform now back on the docket in the U.S. Senate, liberals are crying bloody murder over the purely hypothetical costs to the insured that exist entirely in their heads. But they’re not wrong about one thing: healthcare is too expensive, and the fact that people try to lay the costs of it almost […]

Continue Reading

When Patents Are Bad, Property Rights Suffer

 

While the debate over patent reform has faced something of a lull, with multiple high-profile policy issues currently eating up a large chunk of Congress’s time, this lack of attention should distract nobody. The issue is still alive and well and is very much something that both sides of the aisle should be concerned about, […]

Continue Reading

The CREATES Act Is Back

 

This past Thursday, April 27, a major piece of legislation that deserves far more attention made its debut in the Senate. I refer to the “Creating and Restoring Equal Access to Equivalent Samples Act of 2017,” abbreviated as the CREATES Act of 2017. While this bill originally was scheduled to debut back in February, apparently […]

Continue Reading





Send this to a friend